PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity

Clinical trial NCT00576706 · COMPLETED

Trial details

NCT number: NCT00576706
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis Osteoarthritis Ankylosing Spondylitis

Start date: 2007-12-01
Primary completion: 2010-03-01
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.